Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :29781803
Publication Date : //

Tendency of K562 chronic myeloid leukemia cells towards cell reprogramming.


Cancer cell reprogramming is a potential tool to study cancer progression, disease pathology and drug sensitivity. Prior to performing cancer reprogramming studies, it is important to evaluate the stemness predisposition of cells that will be reprogrammed. Here, we performed a proof-of-concept study with chronic myeloid leukemia K562 cells in order to evaluate their tendency for cancer cell reprogramming. Expression of reprogramming factors, pluripotency markers and tumor-suppressor genes were analyzed at gene and protein level via real-time RT-PCR and flow cytometry. Human PBMCs were used as positive control and K562 cells were shown to express higher levels of most of the reprogramming factors, pluripotency markers. Expression of p53, which is one of the main regulator during iPSC generation were found to be lowed in K562 cells compared to PBMCs, whereas the other tumor-suppressor genes showed higher expression levels. This study suggested that similar to healthy human PBMCs, K526 cells could be used in cancer cell reprogramming studies. Generating iPS cells from leukemia cells could help scientists to establish CML models in vitro, better understand therapy resistance and develop novel therapeutic targets.

Authors : Yılmazer Aktuna Açelya ,

Related products :

Catalog number Product name Quantity
HCL-1204 Human K562 (Chronic Myelogenous Leukemia) lysate 100ug
T18-023-N2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) 0.1 mg
T18-022-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) 0.1 mg
T18-022-N2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) 0.1 mg
T18-021-T2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) 0.1 mg
T18-021-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) 0.1 mg
T18-021-N2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) 0.1 mg
T18-021-N1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) 0.1 mg
T18-022-N1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) 0.1 mg
T18-022-T2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) 0.1 mg
T18-023-N1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) 0.1 mg
T18-023-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) 0.1 mg
T18-023-T2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) 0.1 mg
HCL-1204 Human K562 (Chronic Myelogenous Leukemia) lysate Species Reactivity: Human 100ug Product tipe: Protein Lysate for WB
T18-022-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) tissue 0.1 mg
T18-023-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) tissue 0.1 mg
T18-021-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) tissue 0.1 mg
SL100489-K562 Transfection Reagents and Kits, GenJet™ DNA In Vitro Tranfection Reagent for K562 was pre_optimized for most efficiently transfecting K562 cells. 1 ml
BYA9643-1 CD13, Aminopeptidase N, Chronic Myeloid Leukemia, 150kD, Clone WM_47, Mab anti_Human vial
32-191 Mcl-1 (Myeloid cell leukemia-1) is Bcl-2-related and was identified as an early-induction gene that increased in expression during the differentiation of human myeloblastic leukemia cell ML-1, or expo 0.1 mg
31-076 DOK2 is constitutively tyrosine phosphorylated in hematopoietic progenitors isolated from chronic myelogenous leukemia (CML) patients in the chronic phase. It may be a critical substrate for p210 (bcr 0.05 mg
31-062 DOK1 is constitutively tyrosine phosphorylated in hematopoietic progenitors isolated from chronic myelogenous leukemia (CML) patients in the chronic phase. It may be a critical substrate for p210 (bcr 0.05 mg
L009V1 K-562 (human chronic myelogenous leukemia) whole cell lysate (denatured) 200 ug
L009V2 K-562 (human chronic myelogenous leukemia) whole cell lysate (non-denatured) 200 ug
GTX25535 K-562 cell line slides (human: bone marrow; chronic myelogenous leukemia) other 5 slides


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur